Acquisition - November 23, 2023
ADDvise acquires Axelerist
ADDvise Group has entered into a share purchase agreement with the owner of Axelerist regarding the acquisition of all shares of Axelerist. Closing of the acquisition takes place today, Nov 22 2023. Axelerist Axelerist, based in Yorktown Heights, New York, is a leading provider of tailored rental and purchase solutions of MedTech- and laboratory equipment […]
Financing - November 21, 2023
Texray closes SEK 45 million investment round
Texray has announced the successful completion of an investment round led by Industrifonden and supported by private investors at Impilo. This round significantly exceeded expectations, highlighting the robust investor interest in Texray’s innovative technology, states the company. “We are thrilled by the immense support we have received from investors who would like to join us […]
Acquisition - November 21, 2023
Vironova BioAnalytics acquired by an investor syndicate
Vironova BioAnalytics has announced its acquisition led by QuatreLab (a quality control company created by Columbus Venture Partners) with the participation of Accord Investment Partners and Venture Targeter AB. Following the completion of the acquisition, the company will be renamed and rebranded as QuTEM. “We are excited to join forces with these new partners to […]
Financing - November 13, 2023
BICO has divested Ginolis
BICO has divested Ginolis through a management buy-out to Ginolis’ current CEO Kauko Väinämö. The purchase price amounted to USD 1. The transaction is estimated to result in a divestment loss of SEK -25 million, which is a non-cash item. Final divestment result will be reported and disclosed in the Q4 report, states the company. […]
Financing - November 2, 2023
Sigrid Therapeutics secures USD 4 million
The company has successfully secured financing in an oversubscribed funding round. “This funding will propel our efforts in establishing key partnerships and driving SiPore technology to market. We are thrilled to have the backing of our investors as we move closer to providing effective solutions for obesity and diabetes management,” says Sana Alajmovic, Sigrid’s Co-Founder […]
Clinical Trials - October 23, 2023
Spago Nanomedical to initiate phase I/IIa study in Australia
The company’s application to start the clinical phase I/IIa study, Tumorad-01, with the candidate drug 177Lu-SN201 in cancer patients has been approved. The first patient is expected to be included shortly, states the company. “We are very excited and strongly motivated to now start the first clinical study with Tumorad. The study is designed in […]
